Online citations, reference lists, and bibliographies.
← Back to Search

The Functional Role Of Peroxiredoxin 3 In Reactive Oxygen Species, Apoptosis, And Chemoresistance Of Cancer Cells

Lianqin Li, Ai-Qun Yu
Published 2015 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
PurposeThe mammalian peroxiredoxin (PRX) family contains six members that provide antioxidant defense in different cell types by removing reactive oxygen species (ROS) through conserved active cysteines. Different from other members, PRX3 is predominantly located in mitochondria, a major apoptosis mediator. The purpose of this review is to summarize the findings on PRX3 concerning its role in ROS removal, apoptosis, and chemoresistance of cancer cells.MethodsThe relevant literature from PubMed and Medline databases is reviewed in this article (1994-2014).Results Because of fast growth and relatively low supply of oxygen in cancer cells, ROS production from mitochondria is exaggerated to an extent that overwhelms cellular antioxidant defenses resulting in oxidative stress. As an active responder to oxidative stress, PRX3 is accordingly up-regulated in cancer cells to remove cellular ROS and inhibit apoptosis, which provides a favorable microenvironment for cell proliferation. ConclusionSince most of chemotherapy or radiotherapy for cancers is through ROS increase and apoptotic induction, PRX3 might be involved in the chemotherapeutic resistance of cancers.
This paper references
10.1038/227292A0
Abrin and Ricin: New Anti-tumour Substances
Jung-Yaw Lin (1970)
2004a) a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria
TS Chang (1984)
10.1016/0378-1119(89)90297-7
Cloning of a housekeeping-type gene (MERS) preferentially expressed in murine erythroleukemia cells
Yamamoto Tohru (1989)
Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells.
T. Yamamoto (1989)
10.1073/PNAS.91.15.7017
Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes.
H. Z. Chae (1994)
10.1042/BJ3070377
Mammalian antioxidant protein complements alkylhydroperoxide reductase (ahpC) mutation in Escherichia coli.
K. Tsuji (1995)
10.1111/J.1432-1033.1997.T01-1-00052.X
SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria.
S. Watabe (1997)
10.1006/JMBI.1998.1644
Human T cell cyclophilin18 binds to thiol-specific antioxidant protein Aop1 and stimulates its activity.
A. Jäschke (1998)
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.
H. Zhong (1999)
10.1016/S0168-8227(99)00037-6
Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin.
H. Chae (1999)
10.1074/JBC.274.4.2271
Antioxidant Function of the Mitochondrial Protein SP-22 in the Cardiovascular System*
M. Araki (1999)
The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.
K. Talks (2000)
10.1089/ARS.2000.2.4-801
The mitochondrial thioredoxin system.
A. Miranda-Vizuete (2000)
Identification of c-myc responsive genes using rat cDNA microarray.
Q. Guo (2000)
10.1016/S0002-9440(10)64554-3
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
Kate L. Talks (2000)
10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M
The mitochondrial antioxidant defence system and its response to oxidative stress
T. Rabilloud (2001)
10.1074/JBC.M100571200
Abrin Triggers Cell Death by Inactivating a Thiol-specific Antioxidant Protein*
S. Shih (2001)
10.1074/JBC.M101822200
Cyclophilin A Binds to Peroxiredoxins and Activates Its Peroxidase Activity*
S. Lee (2001)
Overexpression of peroxiredoxin in human breast cancer.
D. Y. Noh (2001)
10.1038/35104560
Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
E. Smaele (2001)
10.1073/pnas.102523299
The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation
D. Wonsey (2002)
10.1002/path.1042
Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma
V. Kinnula (2002)
Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas.
J. H. Choi (2002)
10.1007/S00894-002-0075-Z
A QSPR-Approach to the Estimation of the pKHB of Six-Membered Nitrogen-Heterocycles using Quantum Mechanically Derived Descriptors
M. Hennemann (2002)
10.1007/BF03402079
Nonredundant Antioxidant Defense by Multiple Two-Cysteine Peroxiredoxins in Human Prostate Cancer Cells
C. Shen (2002)
10.1074/JBC.M206066200
Pag, a Putative Tumor Suppressor, Interacts with the Myc Box II Domain of c-Myc and Selectively Alters Its Biological Function and Target Gene Expression*
Z. M. Mu (2002)
Peroxiredoxins in breast carcinoma.
P. Karihtala (2003)
Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis.
L. Nonn (2003)
10.1046/J.1432-1033.2003.03363.X
Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB synergistically.
M. Masaki (2003)
10.4049/jimmunol.171.1.88
Inhibition of Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis1
L. Pham (2003)
10.1074/JBC.M407707200
Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria*
T. Chang (2004)
10.1074/jbc.M409482200
Characterization of Mammalian Sulfiredoxin and Its Reactivation of Hyperoxidized Peroxiredoxin through Reduction of Cysteine Sulfinic Acid in the Active Site to Cysteine*
T. Chang (2004)
10.1002/mc.20031
Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells
P. Srinivas (2004)
10.1016/J.MOLCEL.2005.05.021
Multiple RNA surveillance pathways limit aberrant expression of iron uptake mRNAs and prevent iron toxicity in S. cerevisiae.
A. Lee (2005)
10.1038/nm1320
The antioxidant function of the p53 tumor suppressor
A. Sablina (2005)
RPK118, a PX domain-containing protein, interacts with peroxiredoxin-3 through pseudo-kinase domains.
L. Liu (2005)
10.1016/J.TIBS.2005.06.009
HIF-1α and p53: the ODD couple?
D. Fels (2005)
HIF-1alpha and p53: the ODD couple?
D. Fels (2005)
10.1074/JBC.C400496200
Reduction of Cysteine Sulfinic Acid by Sulfiredoxin Is Specific to 2-Cys Peroxiredoxins*
H. Woo (2005)
10.1002/ijc.21685
Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel‐induced cancer cell death both in vitro and in vivo
J. Alexandre (2006)
10.1111/j.1440-1843.2006.00849.x
Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung
J. Park (2006)
10.1016/J.CCR.2007.04.001
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.
H. Zhang (2007)
10.1158/0008-5472.CAN-06-2401
Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology.
Yun-Jeong Kim (2007)
10.1016/J.MITO.2007.07.003
Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway.
Mayank Singh (2007)
10.1016/J.FREERADBIOMED.2006.12.021
Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.
C. Marzano (2007)
10.1016/j.neulet.2007.12.068
Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+
S. Simoni (2008)
10.1016/j.bcp.2008.08.021
The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation.
A. G. Cox (2008)
10.1016/j.freeradbiomed.2008.04.030
Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanates.
Kristin K. Brown (2008)
10.1074/jbc.M710610200
FOXO3A Regulates Peroxiredoxin III Expression in Human Cardiac Fibroblasts*
Calin B Chiribau (2008)
10.1016/j.freeradbiomed.2007.11.017
Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis.
Andrew G. Cox (2008)
cancer : consistent upregulation of PRDX 3 and PRDX 4
KK Brown (2008)
10.1016/j.canlet.2009.04.043
Peroxiredoxins, a novel target in cancer radiotherapy.
B. Zhang (2009)
10.1002/ijc.24341
Downregulation of the c‐MYC target gene, peroxiredoxin III, contributes to arsenic trioxide‐induced apoptosis in acute promyelocytic leukemia
P. Vivas-Mejía (2009)
10.3892/OR_00000366
Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis.
Kiyoon Kim (2009)
10.1089/ARS.2008.2325
Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia.
Soo Han Bae (2009)
10.1002/jcb.21996
Transcriptional up‐regulation of FoxM1 in response to hypoxia is mediated by HIF‐1
L. Xia (2009)
10.1074/jbc.M808981200
Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III*
Y. H. Noh (2009)
10.1016/j.febslet.2010.06.002
The role of enoyl‐CoA hydratase short chain 1 and peroxiredoxin 3 in PP2‐induced apoptosis in human breast cancer MCF‐7 cells
X. Liu (2010)
10.14670/HH-25.1297
Peroxiredoxins in colorectal neoplasms.
X. Wu (2010)
10.1074/jbc.M110.101196
Respiration-dependent H2O2 Removal in Brain Mitochondria via the Thioredoxin/Peroxiredoxin System*
Derek A. Drechsel (2010)
10.3892/IJO_00000507
Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer.
Pei-Jou Chua (2010)
10.4161/cc.9.6.10955
Thiazole antibiotics against breast cancer
M. Halasi (2010)
10.1074/jbc.M110.185827
Both Thioredoxin 2 and Glutaredoxin 2 Contribute to the Reduction of the Mitochondrial 2-Cys Peroxiredoxin Prx3*
E. Hanschmann (2010)
10.1016/j.febslet.2010.02.042
Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin
Kristin K. Brown (2010)
10.1158/0008-5472.CAN-10-2720
Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose.
H. Okuyama (2010)
10.1152/ajpheart.00535.2009
Regulation of reactive oxygen species by p53: implications for nitric oxide-mediated apoptosis.
D. Popowich (2010)
Thiazole antibiotics against breast cancer. Cell Cycle
M Halasi (2010)
10.1002/pros.21292
Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4
Anamika Basu (2011)
10.1167/iovs.10-5777
Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway.
N. Miyamoto (2011)
10.1038/emboj.2011.323
FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
Kim Steen Jensen (2011)
10.3904/kjim.2011.26.3.304
Nuclear factor E2-related factor 2 Dependent Overexpression of Sulfiredoxin and Peroxiredoxin III in Human Lung Cancer
Y. Kim (2011)
10.3390/ijms12107163
Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
I. Song (2011)
10.1007/s10571-011-9703-4
Upregulation of Peroxiredeoxin III in the Hippocampus of Acute Immobilization Stress Model Rats and the Foxo3a-Dependent Expression in PC12 Cells
H. J. Jeong (2011)
Differential expression of perox - iredoxins in
A Basu (2011)
10.1016/j.molcel.2012.09.025
Physiological roles of mitochondrial reactive oxygen species.
Laura A. Sena (2012)
10.3892/OL.2012.648
Expression and prognostic significance of human peroxiredoxin isoforms in endometrial cancer.
Seulhee Han (2012)
10.1371/journal.pone.0039404
Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
Kheng Newick (2012)
10.1089/ars.2011.4334
Peroxiredoxin III and sulfiredoxin together protect mice from pyrazole-induced oxidative liver injury.
Soo Han Bae (2012)
10.1007/s10787-012-0149-1
The biological activity of auranofin: implications for novel treatment of diseases
J. Madeira (2012)
10.3892/ijmm.2012.916
Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.
B. Qiao (2012)
10.1158/0008-5472.CAN-11-2371
Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells.
Megan R. Doe (2012)
10.1038/cdd.2011.179
FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression
E. C. Ferber (2012)
10.1016/j.febslet.2012.06.003
MicroRNA‐23b downregulates peroxiredoxin III in human prostate cancer
H. He (2012)
10.1007/s10517-012-1849-7
Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation
E. Kalinina (2012)
Expression and prognostic significance
S Han (2012)
10.3892/mmr.2013.1370
siRNA targeting of PRDX3 enhances cisplatin‑induced apoptosis in ovarian cancer cells through the suppression of the NF‑κB signaling pathway.
J. Duan (2013)
10.1016/j.fob.2012.12.002
Anti-apoptotic role of peroxiredoxin III in cervical cancer cells☆
Lianqin Li (2013)
10.1007/s13277-013-0769-0
Peroxiredoxin III protein expression is associated with platinum resistance in epithelial ovarian cancer
Xin-yan Wang (2013)
10.3892/BR.2012.43
Peroxiredoxin 3 is a novel marker for cell proliferation in cervical cancer.
Jing-xia Hu (2013)
10.1016/j.bbrc.2012.12.006
c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α.
Cheng Chen (2013)
10.3109/07357907.2013.802798
Peroxiredoxin Overexpression in MCF-7 Breast Cancer Cells and Regulation by Cell Proliferation and Oxidative Stress
Lauren Tehan (2013)
10.1002/jcp.24232
Mitochondrial‐targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells
B. Cunniff (2013)
10.1038/bjc.2013.396
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
H. Whitaker (2013)
10.1007/s12094-013-1117-y
Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells
Y-G Wang (2013)
10.1111/bpa.12014
MiR‐383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3)
K. Li (2013)
10.1186/1476-4598-12-93
Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses
Joanna Obacz (2013)
10.3892/ijo.2014.2398
Peroxiredoxin proteins protect MCF-7 breast cancer cells from doxorubicin-induced toxicity.
C. McDonald (2014)
2013) siRNA targeting of PRDX3 enhances cisplatin—induced apoptosis in ovarian cancer cells through the suppression of the NF–κB signaling pathway
J Duan
Rhee SG (2004a) a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria
Ts Chang



This paper is referenced by
10.3390/pharmaceutics13050762
Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
Martina Godel (2021)
10.3390/biom10010135
Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer
R. Avolio (2020)
10.3390/ijms20184407
Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression
T. Ismail (2019)
10.20944/preprints201908.0193.v1
The Expression and Prognostic Role of Peroxiredoxins in Lung Cancer
B. Li (2019)
10.15430/JCP.2019.24.2.65
The Role of Peroxiredoxin Family in Cancer Signaling
Yosup Kim (2019)
10.1016/j.bbrc.2018.06.145
SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis.
D. Huynh (2018)
Tanshinone l exhibits anticancer effects in human endometrial carcinoma HEC-1-A cells via mitochondrial mediated apoptosis, cell cycle arrest and inhibition of JAK/STAT signalling pathway.
Q. Li (2018)
10.5772/INTECHOPEN.74925
Spontaneous Unexplained Preterm Labor with Intact Membrane: Finding Protein Biomarkers through Placenta Proteome
N. J. Tan (2018)
10.1016/j.drup.2018.11.001
Modulating ROS to overcome multidrug resistance in cancer.
Qingbin Cui (2018)
10.25148/etd.FIDC006857
Interaction of High Molecular Weight Compounds with a, β-Unsaturated Carbonyl Moiety with Mammalian and Drosophila Melanogaster Thioredoxin Reductase
Anupama Tuladhar (2018)
10.3390/ijms18102119
Transforming Growth Factor-β Drives the Transendothelial Migration of Hepatocellular Carcinoma Cells
Petra Koudelková (2017)
10.3389/fcell.2017.00065
New Challenges to Study Heterogeneity in Cancer Redox Metabolism
R. Benfeitas (2017)
Characterization and Expression Analysis of Peroxiredoxin Genes in NNK-induced V 79 Cells *
Shiyue Qin (2017)
10.3967/bes2017.031
Characterization and Expression Analysis of Peroxiredoxin Genes in NNK-induced V79 Cells.
G. Q. Shi (2017)
10.3892/mco.2017.1129
The role of peroxiredoxins in cancer
A. Nicolussi (2017)
10.1007/978-3-319-67591-6_7
Roles of the Translationally Controlled Tumor Protein (TCTP) in Plant Development.
Léo Betsch (2017)
10.1016/j.bbadis.2016.10.017
Mitochondrial peroxiredoxins are essential in regulating the relationship between Drosophila immunity and aging.
O. Odnokoz (2017)
10.3892/mmr.2016.5881
Mitochondrial transcription factor A contributes to cisplatin resistance in patients with estrogen receptor‑positive breast cancer.
W. Gao (2016)
10.4110/in.2016.16.6.373
Peroxiredoxin-3 Is Involved in Bactericidal Activity through the Regulation of Mitochondrial Reactive Oxygen Species
S. Lee (2016)
10.1016/j.str.2016.04.013
Structures of Human Peroxiredoxin 3 Suggest Self-Chaperoning Assembly that Maintains Catalytic State.
N. A. Yewdall (2016)
10.1017/S1431927616001203
Solution Conformations of Peroxiredoxins Visualised by Volta Phase Plates
M. Radjainia (2016)
10.1021/acs.biochem.5b00758
Molecular Basis of Hydroperoxide Specificity in Peroxiredoxins: The Case of AhpE from Mycobacterium tuberculosis.
Ari Zeida (2015)
Semantic Scholar Logo Some data provided by SemanticScholar